BR Form 4: CEO Gokey Exercises 146,392 Options, Sells 134,822 Shares
Rhea-AI Filing Summary
Broadridge Financial Solutions (BR) insider transactions summary: The company's CEO, Timothy C. Gokey, executed stock option exercises and sold common shares under a pre-established 10b5-1 plan. On 08/13/2025 he exercised options to acquire 46,561 shares at an exercise price of $93.88 and sold 39,251 shares at a weighted average price of $262.4552. On 08/14/2025 he exercised options to acquire 99,831 shares at $98.31 and sold 84,571 shares at a weighted average price of $259.5296. On 08/15/2025 he sold an additional 11,000 shares at a weighted average price of $259.2871. After these reported transactions the filing shows 154,634.0271 shares beneficially owned.
Positive
- None.
Negative
- None.
Insights
TL;DR: Insider engaged in planned option exercises and systematic share sales under a 10b5-1 plan; activity appears routine and prearranged.
This Form 4 discloses the CEO's exercise of two stock option tranches (46,561 and 99,831 options) and multiple open-market sales executed pursuant to a 10b5-1 plan adopted May 14, 2025. The sales were executed at weighted average prices in the $258.72–$263.99 ranges as disclosed. The transactions are explicitly identified as planned (10b5-1), which limits informational surprise to the market. The filing reports the reporting person retains 154,634.0271 shares following the activity.
TL;DR: Use of a 10b5-1 plan indicates compliance with insider trading controls; disclosures are detailed and include price ranges.
The filing clearly states the transactions were executed pursuant to a 10b5-1 plan adopted May 14, 2025, and provides weighted average prices plus ranges for the multiple sales. Footnotes commit the reporting person to provide detailed per-trade pricing on request, which enhances transparency. The pattern—option exercises followed by sales—matches common post-exercise liquidity actions by executives and was reported with required specificity.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 11,000 | $259.2871 | $2.85M |
| Exercise | Stock Option (Right to Buy) | 99,831 | $0.00 | -- |
| Exercise | Common Stock | 99,831 | $98.31 | $9.81M |
| Sale | Common Stock | 84,571 | $259.5296 | $21.95M |
| Exercise | Stock Option (Right to Buy) | 46,561 | $93.88 | $4.37M |
| Exercise | Common Stock | 46,561 | $93.88 | $4.37M |
| Sale | Common Stock | 39,251 | $262.4552 | $10.30M |
Footnotes (1)
- The reported transaction is a stock option exercise pursuant to a 10b5-1 plan adopted by the reporting person on May 14, 2025. The reported transaction is an open market sale pursuant to a 10b5-1 plan adopted by the reporting person May 14, 2025. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $261.4100 - $263.9900, inclusive. The reporting person undertakes to provide to Broadridge Financial Solutions, Inc., any shareholder of Broadridge Financial Solutions, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (3) to this Form 4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $258.72 - $260.73, inclusive. The reporting person undertakes to provide to Broadridge Financial Solutions, Inc., any shareholder of Broadridge Financial Solutions, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (4) to this Form 4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $257.12 - $260.53, inclusive. The reporting person undertakes to provide to Broadridge Financial Solutions, Inc., any shareholder of Broadridge Financial Solutions, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (5) to this Form 4.